Oxford Immunotec joined with Public Health England in large clinical trial utilizing T-SPOT discovery SARS-CoV-2 test
On Sept. 22, 2020, Oxford Immunotec announced that it had entered into an extensive research collaboration with Public…
On Sept. 22, 2020, Oxford Immunotec announced that it had entered into an extensive research collaboration with Public…
On Sept. 22, 2020, Codagenix announced that the Serum Institute of India has begun manufacturing CDX-005, the company’s…
On Sept. 21, 2020, a study comparing the immune responses of adults and children with COVID-19 detected key…
On Sept. 21, 2020, XBiotech announced it was developing a new breakthrough candidate therapy it calls FLUVIDï¾™ for…
On Sept. 18, 2020, Sanofi and GSK finalised and signed an advanced purchase agreement with the European Commission…
On Sept. 18, 2020, Uconn researchers, in a paper published in Nature Communications, validated the clinical feasibility of…
On Sept. 17, 2020, Eli Lilly and Amgen announced a global antibody manufacturing collaboration to significantly increase the…
On Sept. 17, 2020, Rigel Pharma announced the start of a multicenter, Phase 2 trial to evaluate the…
On Sept. 17, 2020, researchers announced a CRISPR-based test developed at MIT and the Broad Institute that can…
On Sept. 17, 2020, Quest Diagnostics announced that individuals can purchase a test to diagnose COVID-19 online, without…
On Sept. 17, 2020, BioNTech announced an agreement with Novartis to acquire their GMP certified manufacturing facility in…
On Sept. 17, 2020, Atossa Therapeutics announced a positive interim safety assessment from the second cohort of healthy…
On Sept. 17, 2020, Roche announced that the phase III EMPACTA study met its primary endpoint, showing that…
On Sept. 16, 2020, the NIH announced a $12 million award for outreach and engagement efforts in ethnic…
On Sept. 16, 2020, Eli Lilly announced proof of concept data from an interim analysis of the BLAZE-1…
On Sept. 16, 2020, a study by researchers at La Jolla Institute for Immunology published in the Cell,…
On Sept. 16, 2020, NanoViricides announced that it had nominated a clinical drug candidate for the treatment of…
On Sept. 16, 2020, AIM ImmunoTech announced that recruitment had begun in Roswell Park Comprehensive Cancer Center’s Phase…
On Sept. 16, 2020, AXIM Biotechnologies announced that it had filed an Emergency Use Authorization (EUA) application with…
On Sept. 15, 2020, Novavax announced an amendment to its existing agreement with Serum Institute of India which…
On Sept. 15, 2020, initial findings reported by the Arizona COVID-19 Genomics Union (ACGU) suggested that following Arizona’s…
On Sept. 15, 2020, the NIH awarded seven contracts worth a total of $22.8 million to companies and…
On Sept. 15, 2020, the FDA published comparative performance data for some authorized COVID-19 molecular diagnostic tests. The…
On Sept. 15, 2020, Vaxess Technologies and Medigen Vaccine Biologics (MBV) announced a partnership to develop a combined…
On Sept. 15, 2020, Thermo Fisher Scientific announced it was investing more than $140 million to further expand…
On Sept. 15, 2020,Tonix Pharmaceuticals announced that the first patient was enrolled in the observational COV-LOGIC study (TNX-C001),…
On Sept. 15, 2020, OPKO Health announce it had initiated a Phase 2 trial with RAYALDEEï¾® as a…
On Sept. 15, 2020, UT Southwestern research suggested conditions related to obesity, including inflammation and leaky gut, leave…
On Sept. 15, 2020, the University of Texas Health Science Center at Houston (UTHealth) announced that a study…
On Sept. 14, 2020, scientists at the Max Planck Institute for Infection Biology in Berlin and the Institut…